Blume-Jensen Peter

Track

Insider profile

Performance

Overall performance
2.7
Performance over holding periods
4.2
30 days 90 days 120 days
Average return -0% 8.2% 15.1%
Success rate 30% 68% 82%
Transactions
4 25% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return 30%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance
Blume-Jensen Peter's trades of Acrivon Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-27 2026-08-25
S Sale
87,833 +25.0%
240.04
US$4,648,169 		87,833 +25.0% 240.04 US$4,648,169
2026-08-25 2026-08-25
PrS Proposed sale
68,688
370.63
US$466,436 		68,688 370.63 US$466,436
2026-08-20 2026-08-18
S Sale
9,156 -38.7%
364.99
US$2,231,591 		9,156 -38.7% 364.99 US$2,231,591
2026-08-20 2026-08-18
S Sale
1,229 -0.1%
2.01
US$2,470 		1,229 -0.1% 2.01 US$2,470
2026-01-16 2026-01-14
B Purchase
49,000 +2.4%
1.68
US$82,124 		49,000 +2.4% 1.68 US$82,124